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OCULOMOTOR NERVE SCHWANNOMA: CASE SERIES AND LITERATURE 
REVIEW 
CHRISTOPHER FLORES 
ABSTRACT 
Purpose: To develop an algorithm in order to establish a consensus on how 
oculomotor nerve schwannomas should be treated by reviewing results from 
reported cases in the literature. Given the rarity of oculomotor nerve 
schwannomas, there is no agreed upon criteria for when a surgical or a 
nonsurgical intervention would be indicated. By reviewing former cases of 
oculomotor nerve schwannomas, our study proposes a flowchart for physicians 
to follow for optimal management. 
Methods: The review of reported oculomotor nerve schwannoma cases involved 
51 cases. From the 51 cases, data was tabulated including age, patient 
symptoms, symptom duration, tumor size, tumor location, treatment, post 
operative results, and follow up time. The cases were then divided in to surgical 
subgroup and a nonsurgical subgroup. Each case was also grouped based on 
post operative oculomotor function into improved, no change, and worsened 
groups. Our collaboration with Tufts Medical center also yielded 4 unreported 
cases of oculomotor nerve schwannoma that are described and compared to the 
previous 51 cases from the literature review.  
Results: The review of the 51 reported cases yielded a few statistically 
significance differences between the surgical and nonsurgical subgroups. The 
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surgical subgroup was older with a mean age of 35 years than the nonsurgical 
subgroup with a mean age of 15.8 years. The surgical group also had larger 
tumors with a mean tumor diameter of 29.5 mm versus the nonsurgical 
subgroup's 4.5 mm mean tumor diameter. The surgical subgroup also 
experienced shorter symptom durations as well. The mean duration of symptoms 
in the surgical subgroup was 17.8 months versus the 140 month mean symptom 
duration for the nonsurgical cases. Finally, the majority of surgically treated 
cases experienced a worsening of residual oculomotor function (20/38), while the 
majority of nonsurgically treated cases experienced little to no change in 
oculomotor function (11/13). 
Conclusion: Given the high likelihood of complete third nerve palsy after 
surgery, this study advocates a conservative approach to oculomotor nerve 
schwannomas that do not present with any life threatening symptoms or acutely 
deteriorating symptoms. The cases that are presented in this study also 
corroborate previous studies' findings on the efficacy of stereotactic radiosurgery 
in managing schwannoma size without resorting to more invasive interventions.    
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INTRODUCTION 
 
 Diplopia, or double vision, is a common symptom experienced by a 
wide variety of patients young and old. Diplopia is typically the result of 
extraocular muscle dysfunction, which prevents both eyes from effectively 
focusing at the same point. Double vision can prove to be quite debilitating when 
carrying out everyday tasks, thus it is important to understand the many different 
causes of impaired extraocular motor function. Often times the problem involves 
one of the cranial nerves that innervate the extraocular muscles, resulting in 
strabismus, the medical term for misaligned eyes. An uncommon cause of 
diplopia are schwannomas, also called neurinomas or neurilemomas, of the 
oculomotor nerve. This study intends to present a comprehensive review of 
previous cases and present four undocumented cases of oculomotor nerve 
schwannoma. Given the information from previous literature and the case series, 
this study will propose an algorithm for future physicians to follow when they 
come across this rare tumor in order to preserve as much residual oculomotor 
function as possible. 
 
The Oculomotor Nerve 
 The twelve cranial nerves are responsible for controlling both involuntary 
and somatic muscles in the head, as well as, transmitting sensory information 
from the head and neck. All of the cranial nerve cell bodies can be found in the 
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brainstem and generally lie on the base of the skull. The oculomotor nerve cell 
nuclei are mainly found near the superior colliculus, a structure in the midbrain 
that is primarily involved with integrating visual and oculomotor information. The 
oculomotor nerve plays an important role in both general somatic efferent (GSE) 
and general visceral efferent innervation (GVE). General somatic efferent 
function refers to nerves that will control voluntary muscles, while general 
visceral efferent refers to nerves that control involuntary smooth muscle tissue. 
The subnucleus of the GVE innervation is referred to as the Edinger-Westphal 
nucleus, which is right next to the somatic nuclei. (Binder et al., 2010) 
 
Figure 1-Oculomotor Nuclei. 8 and 7 show the locations of the Edinger-Westphal 
nucleus and the somatic nucleus. The neurons from these nuclei come together to 
form the oculomotor nerve, labeled 5. Figure taken from Binder et al., 2010. 
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The primary somatic targets for the oculomotor nerve include the superior 
rectus, the inferior rectus, the medial rectus, the inferior oblique, and the levator 
palpebrae superioris. Each of these muscles are responsible for moving the eye 
in a specific direction. The superior rectus muscle (SR) works to elevate the eye. 
The inferior rectus (IR) will oppose the SR and depress the eye. The medial 
rectus (MR) helps adduct the eye, which will move the eye in a medial direction. 
The inferior oblique (IO) will facilitate extorsion of the eye. Finally, the levator 
palebrae superioris (LPS) is responsible for elevating the upper eyelid. The only 
visceral targets of the oculomotor nerve are the sphincter pupillae and the ciliary 
muscles, which are involved in constricting the pupil and changing the size of the 
lens respectively. (Binder et al., 2010) 
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Figure 2 – Oculomotor nerve path. The oculomotor nerve, labeled III, is shown starting 
from the midbrain and passing between the superior cerebellar and the posterior 
cerebral arteries. Figure taken from Binder et al., 2010. 
  
 In order to reach 
its intended targets, the 
oculomotor nerve must 
first pass through a 
subarachnoid space 
known as the 
interpeduncular cistern 
once it exits the 
midbrain. After 
traversing this 
subarachnoid space the 
oculomotor nerve then passes through the cavernous sinus and runs along the 
superior lateral wall of the sinus until it reaches the superior orbital fissure. Just 
before the nerve leaves the cavernous sinus, it divides into a superior and inferior 
division in order to reach each of the muscles that it will innervate. (Binder et al., 
2010) While the oculomotor nerve and the other cranial nerves are in close 
approximation with the brain, they are considered components of the peripheral 
nervous system. As a result, the primary glial cell that will support and myelinate 
the oculomotor nerve is the Schwann cell. The exception to this rule is the optic 
Figure 3 - Cavernous sinus. The oculomotor nerve is 
show, from a coronal view, running along the 
superiolateral wall of the cavernous sinus. The 
oculomotor nerve is in close approximation with the 
other cranial nerves. Figure taken from Gray H., 1918. 
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nerve (cranial nerve II), which is myelinated by oligodendrocytes. The optic 
nerves are unique due to their development from the optic stalks which directly 
budded off from the diencephalon. (Wowra & Tonn, 2010) 
 
Third Nerve Palsy 
 Lesions affecting the oculomotor nerve will result in complete or 
incomplete paralysis of the muscles innervated by the third nerve. This paralysis 
results in a multitude of related symptoms that define third nerve palsy. The most 
obvious symptom seen in third nerve palsy is ptosis, which is drooping of the 
upper eyelid. The ptosis seen in oculomotor lesions is the result of the paralysis 
of the levator palebrae superioris muscle. The only muscles not innervated by the 
oculomotor nerve are the superior oblique (SO), which has a secondary action of 
depressing the eye, and the lateral rectus (LR), which abducts the eye. A patient 
suffering from third nerve palsy will also have a characteristic down and out 
orientation of the eye. The characteristic eye deviation seen in third nerve palsy 
is the result of the unopposed actions of the SO and LR. The resulting exotropia, 
the term for an outward deviation of the eye, will then lead to diplopia when the 
drooping eyelid is lifted to expose the effected eye. (Mumenthaler & Mattle, 2004) 
 Another common finding in third nerve palsy is anisocoria, which is the 
medical term for unequal pupil sizes. The affected eye will usually have a dilated 
pupil and diminished reactivity to light due to the lack of sphincter pupillae 
activity. The location of the oculomotor lesion will also have an effect on the 
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symptoms. Typically, lesions in the cisternal space will only present with isolated 
third nerve palsy, but lesions in the cavernous sinus can potentially affect other 
cranial nerves running near the oculomotor nerve. Interestingly, a compressive 
injury affects the pupil before it affects the extraocular muscles. (Mumenthaler & 
Mattle, 2004)   
Occasionally, a slight bulging (exophthalmos) of the affected eye can be 
noted in third nerve palsy due to the loss of medial, superior, and inferior rectus 
muscle activity. The recti in a healthy individual also serve, in a limited capacity, 
to ensure the eye remains in the orbit. A patient with long standing third nerve 
palsy could also present with noticeable extraocular muscle atrophy in the 
muscles innervated by the oculomotor nerve in magnetic resonance images. 
(Mumenthaler & Mattle, 2004) Atrophy of skeletal muscle is a common response 
to the denervation of certain structures and is referred to as neurogenic muscle 
atrophy. (Berridge et al., 2013) 
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Figure 4 – Example of common findings in third nerve palsy. The figure 
demonstrates the extraocular muscle paralysis seen in patients with symptomatic 
oculomotor schwannoma. The effected eye has the characteristic down and out 
orientation and tape is needed to keep the upper lid open. Figure taken from Kim et al., 
2014. 
Third nerve palsy can result from a multitude of etiologies. Aneurysms are 
a common etiology that can lead to compression of the oculomotor nerve. More 
specifically, cisternal compression usually results from posterior communicating 
artery aneurysms, while cavernous compressions typically arise from aneurysms 
of the internal carotid artery. (Levin & Arnold, 2005) Pituitary tumors can also be 
the source of third nerve lesions in the cavernous sinus due to the gland's close 
proximity to the oculomotor nerve and other important extraocular cranial nerves. 
Though very rare today, sphenoid sinusitis and meningitis caused by a variety of 
bacterial and fungal pathogens has been shown to result in paresis of the 
oculomotor nerve and other cranial nerves. (Petrick et al., 2003) Tumors arising 
directly from the oculomotor nerve are also potential causes of paresis. This 
study was particularly interested with schwannomas, which are the result of over 
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proliferating Schwann cells. With a dizzying array of potentially lethal causes of a 
third nerve palsy, it is vital for physicians to rule out as many causes as efficiently 
as possible. Magnetic resonance imaging has proven to be the most powerful 
imaging modality for confirming the exact causes of third nerve palsy, including 
oculomotor schwannomas. 
 
Magnetic Resonance Imaging 
 Magnetic resonance imaging (MRI) has proven to be an invaluable tool in 
visualizing cranial nerves and identifying potential lesions. Unlike computerized 
tomography, MRI does not rely on ionizing radiation to generate an image but 
rather magnetic fields and radio waves. MRI primarily works by inducing a strong 
uniform magnetic field on to a tissue. This magnetic field is typically 1.5 T and 
takes advantage of the proton’s unique quantum properties. When the protons in 
fat and water are exposed to the uniform field, their angular momentums, or 
spins, are aligned in a parallel to the external magnetic field. Once aligned, the 
protons are capable of being excited to a higher energy state by a radiofrequency 
pulse. In other words, the radio pulse “knocks” the proton away from its stable 
orientation that was parallel to the external field. After the proton is excited, it will 
eventually return to its stable state. This relaxation results in the emission of a 
subsequent radiofrequency photon, which is detected and used to generate an 
image. (Ramsey et al., 2004) 
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 The power of MRI stems from the fact that protons in different tissues or 
fluids relax at different rates and will release photons at different times. There are 
also two different types of relaxation. Spin-lattice relaxation (T1) refers to the time 
it takes the proton to realign with the external magnetic field. Spin-spin relaxation 
(T2) refers to the time it takes the proton to become out of phase with other 
nuclei that are spinning transversely from the external magnetic field. In general, 
T2 relaxation occurs much faster than T1 relaxation. Both T1 and T2 relaxations 
are faster in fat then they are in fluids. It is important to note that a T1 signal will 
increase over time, while T2 signal will decrease over time. In order to take 
advantage of the differences in relaxation times, technicians will change the time 
between radiofrequency pulses and the time interval when the detectors will pick 
up the signal. For T1 weighted images, the intervals between pulses and 
detections will be very short in order to visualize structures that reach their peak 
T1 signal rapidly. In T2 weighted images, the intervals are very long in order to 
visualize structures that have maintained their T2 signal intensity. That is why fat, 
with its short T1 relaxation time, will be a bright white in T1 weighted images and 
fluid, with its long T2 relaxation time, will be white on T2 weighted images. 
(Brown et al., 2005)   
Certain contrast agents can further supplement the resolving power of 
MRI as well. One common contrast agent is gadolinium. The use of 
paramagnetic agents, such as gadolinium, helps to make T1 relaxation times 
shorter by acting as a chelating agent and attracting the water molecules present 
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in a structure. Coordination with the gadolinium helps to stabilize water 
molecules and reorient the protons along the magnetic field faster, which results 
in a more intense T1 signal. (Caille et al., 1983) Thus, structures with large 
concentrations of contrast media will appear more intense in T1 weighted scans. 
If a lesion preferentially takes up or rejects the contrast agent then the intensity of 
the tumor will be noticeably different than its previous intensity without the 
contrast media. (Varma et al., 1992) 
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. 
 The noninvasive nature of MRI makes it a safe and detailed method of 
diagnosing lesions of the oculomotor nerve. In T1 weighted scans the oculomotor 
nerve appears as a similar intensity as the white matter of the brain, but in T2 
weighted scan the oculomotor nerve is a dark, less intense structure that can be 
Figure 5 - Oculomotor nerve schwannoma MRI. The post contrast T1 
weighted scan above shows the characteristic imaging properties of an 
oculomotor nerve schwannoma. Figure taken from Kumar et al., 2014 
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easily followed to the its target muscles. Schwannomas will appear less intense 
in T1 weighted scans and very intense in T2 weighted scans. An important 
characteristic of schwannomas is the hyperintense appearance that the tumor 
takes on after exposure to gadolinium contrast media. (Fabiano et al., 2012) The 
radical change of the T1 relaxation characteristics in the presence of gadolinium 
is often used as an important clue for accurately determining the exact lesion that 
is causing oculomotor deficit. (Kumar et al., 2014) 
 
Schwannomas 
 Schwannomas are the result of neoplastic Schwann cells, that myelinate 
and support peripheral nerve axons. While occasionally malignant, 
schwannomas are normally benign and well circumscribed. (Behuria et al., 2015) 
It is important to note that schwannomas are solely comprised of the myelinating 
cells and do not involve over proliferation of any other cells found in the 
peripheral nervous system. This results in the tumor developing in a well-defined 
capsule which begins to compress the other components of the peripheral nerve 
as it grows. (Wippold et al., 2007) This compression results in the characteristic 
symptoms of third nerve palsy when the oculomotor nerve is involved. 
Schwannomas typically are slower growing tumors that can exist undetected for 
long periods of time. Given the benign nature of schwann cell tumors, the most 
pressing concern for patients with cranial nerve schwannomas is the potential 
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mass effect the tumor might have on other vital structures of the brain. (Vilanova 
et al., 1982) 
 On a molecular level, schwannomas have been linked to the deletion of 
the NF2 gene, which codes for the tumor suppressor known as merlin. Merlin has 
been shown in previous studies to regulate components of both the MAP kinase 
signaling pathway and the PI3K-Ark-mTOR pathway. (Chadee et al., 2006) 
(Rong et al., 2004) It is also important to note that the NF2 deletion is the primary 
mutation in the genetic disorder neurofibromatosis 2, which is characterized 
primarily by schwannomas throughout the body including the cranial nerves. 
(Ruggieri et al., 2016) Another unique molecular characteristic of schwannomas 
is the overexpression of the glycoprotein laminin. In healthy Schwann cells, 
laminin plays an important role in the formation of basement membranes and cell 
adhesion. These properties aid the Schwann cell with myelinating and adhering 
to peripheral nerve axons. (Miettinen et al. 1983) Interestingly, S-100 protein is 
also an important biomarker for schwannomas. S-100 protein is commonly seen 
in many tumors that originate from neural crest cells. It is believed that S-100 
helps the Schwann cell to effectively regulate the neuron’s ionic environment. 
(Weiss et al., 1983) The various molecular characteristics seen in schwannomas 
appear to have a connection to the interesting histological characteristics of the 
tumor.   
 On a histological level, schwannomas are characterized by two distinct 
regions known as Antoni A and Antoni B regions. The Antoni A region is a highly 
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cellular area that contains many spindle shaped nuclei that are palisaded in what 
are called Varocay bodies. The Varocay bodies appear as two nuclear palisades 
separated by an anuclear zone. (Wippold et al., 2007) Previous experiments 
have shown the presence of laminin to be important to the formation of the 
Varocay bodies. It is hypothesized that laminin facilitates the cell adhesion and 
the formation of a continuous basement membrane that is shared by the 
proliferating cells. S-100 production is also shown to increase in the presence of 
laminin. (Weiner et al., 2001) 
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Figure 6 - Antoni A region. Clear signs of palisading and the formation of 
Varocay bodies can be seen in the highly cellular Antoni A region in a 
schwannoma biopsy. Figure taken from Wippold et al., 2006. 
  
Antoni B regions are dramatically less cellular, when compared to Antoni 
A regions. In comparison to the cells in the Antoni A region, the Antoni B cells are 
much thinner with more space in between individual cells. These spaces, 
commonly referred to a microcysts, are filled with mucin. (McLendon et al., 2000) 
It is believed that the congregation of microcysts leads to the cystic appearance 
of some schwannomas especially in neoplasms effecting cranial nerves. Antoni B 
tissue is also denoted by the prevalence of hyalinized blood vessels, which has 
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led many to believe that Antoni B tissue is result of necrotic Antoni A regions 
(Kelly et al., 1976) (Sian & Ryan, 1981). In the past, the prevalence of Antoni B 
tissue has been correlated to both the size of the schwannoma and the 
characteristic heterogeneity of larger schwannomas in MRI scans. (Ando et al., 
2017) 
Figure 7 - Antoni B Region. Shown on the left of the figure is the Antoni B 
region. The Antoni B region is markedly less cellular that the Antoni A region 
(right). Figure taken from Wippold et al. 2007. 
 
Intracranial schwannomas compose approximately 8% of all intracranial 
tumors. The majority of these schwannomas derive from the vestibulocochlear 
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nerve. Only 2.9% to 4% of all schwannomas, without the presence of 
neurofibromatosis II, arise from nonvestibular cranial nerves, such as the 
oculomotor nerve. (Furtado & Hegde, 2012) Along with potential cranial nerve 
paresis, nonvestibular intracranial schwannomas can also mimic 
ophthalmoplegic migraine, also referred to as recurrent painful ophthalmoplegic 
neuropathy. (Kim et al., 2015) One complicating factor for accurately determining 
the frequency of oculomotor schwannomas is the presence of asymptomatic 
schwannomas that have been found coincidentally in various patients. (Katoh et 
al., 2000) 
 
Surgical Resection 
Surgical resection is the preferred method of treating large oculomotor 
nerve schwannomas (Peciu-Florianu et al., 2017). Frontotemporal craniotomy 
and related procedures are the most common surgical approach used to remove 
oculomotor schwannomas. The frontotemporal approach is valued for its capacity 
to expose a variety of structures running through the cavernous sinus and the 
interpeduncular cistern with minimal brain retraction injury. The procedure 
typically involves the use of a microscope in order to assist the surgeon to 
navigate through the crowded structures found in the cavernous sinus. It is 
important to ensure venous drainage is not compromised during the procedure. 
(Kempe, 1968) As microsurgical techniques improved over the years, surgeons 
have reported increasingly positive post-operative results. In the past, complete 
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Figure 8 – View of cavernous sinus during craniotomy. The figure above shows 
how the oculomotor nerve, labeled 4, is exposed during a frontotemporal-zygomatic 
craniotomy. 1 shows the choroidal arteries. 2 shows the Basal artery. 3 shows the 
posterior cerebral artery. 5 shows the superior cerebellar artery. 6 shows the 
posterior communicating artery.  Figure taken from Zhou et al., 2011. 
third nerve palsy was a more common occurrence after surgery. Typically, 
surgery was reserved for especially large or debilitating schwannomas. Today, 
some post-operative, partial third nerve palsy can be expected. However, 
surgeons now have the capacity to safely remove smaller tumors with much less 
complications then their predecessors. (Iaconetta et al., 2010) 
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Stereotactic Radio Surgery 
 Stereotactic radiosurgery (SRS) is also a common treatment for 
oculomotor nerve tumors and intracranial schwannomas in general. More 
specifically, Gamma Knife radio surgery is used in order to reduce tumor size. 
Gamma Knife stereotactic radio surgery was first developed in the 1960’s by 
Swedish physician and professor, Lars Leksell. Cobalt-60 isotope is the primary 
photon source for Gamma Knife, which decays into a non-radioactive nickel 
isotope by releasing a beta particle and two gamma particles. The particles of 
interest are the gamma photons that are emitted. When the high energy photons, 
reach the target tissue, a phenomenon known as Compton scattering occurs. 
Compton scattering results when a photon strikes and ejects an atom’s electron. 
As a result of the collision, the photon is then scattered in another direction. This 
phenomenon typically results at photon energies within 100 keV and 10 MeV, 
which encompasses the energies of the two gamma particles that are released 
during Cobalt-60 decay (1.17 MeV and 1.33 MeV). (Niranjan et al., 2015) 
 Compared to other sources of ionizing radiation, a single beam of gamma 
particles from Cobalt-60 is fairly weak. To amplify the effective power, multiple 
radiation sources are oriented in a hemispherical array. Once the beams 
converge, enough high energy photons are present in order to administer the 
appropriate dose. In order to ensure that the different beams meet at the 
appropriate target, the patient’s head is securely fastened to a specialized helmet 
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that is comprised of an array of 
linear accelerators. (Niranjan et 
al., 2015) The primary advantage 
of Gamma Knife radio surgery, 
compared to other stereotactic 
modalities, is the reduced 
damage to surrounding healthy 
tissue. Only a single weak 
ionizing beam is moving though 
any portion of the brain at a time 
until the beams converge at the 
tumor. Gamma Knife radio 
surgery is common procedure for 
managing residual oculomotor 
schwannomas that could not be 
completely resected as well as other intracranial schwannomas, such as 
vestibular schwannomas. (Elsharkawy et al., 2012) 
 
Strabismus Correction 
Strabismus can be the result of many different disorders. As a result, 
physicians have developed numerous techniques that directly address the 
underlying cause of diplopia. Many cases of strabismus can be corrected in a 
Figure 9 – Basic Gamma Knife diagram. 
The figure above demonstrates how multiple 
radiation sources are used to concentrate 
ionizing photons on a specific point. Figure 
taken from Niranjan et al., 2015. 
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single, one-day surgical procedure. The basic goal of strabismus surgery is to 
adjust where the extraocular muscles insert on the eye itself. (Asproudis et al., 
2017) By moving the insertion point of any extraocular muscle more posteriorly 
on the eye, the surgeon can effectively loosen the muscle and reduce its 
individual effect on eye positioning. The opposite tightening effect can be 
achieved by moving the muscle insertion more anteriorly. More commonly a 
tightening effect can be achieved by inserting a shorter, resected muscle on its 
original insertion point. (Phillips, 2007) By tightening the muscle movement away 
from the resected muscle becomes more restricted. The first successful 
strabismus surgery was performed in 1839. Over the years, strabismus surgery 
has become very commonplace and is one of the most common eye surgeries in 
the United States. Recent developments in minimally invasive techniques plus 
nearly two centuries of experience make strabismus surgery a very attractive 
intervention; especially for patients that continue to have partial third nerve 
palsies after having a schwannoma resected. (Mojon, 2007) 
 Another even less invasive corrective measure is prismatic correction. 
Prism glasses are used to adjust an image in either a vertical direction, horizontal 
direction, or a combination of the two. By adjusting the image a patient sees it is 
possible to correct for diplopia that occurs due to misalignment without putting 
any strain on the extraocular muscles. When light passes through a prism, it gets 
refracted toward the base of the prism. Physicians can adjust the degree light is 
refracted by altering the angle at the apex of the prism. (Gunton & Brown, 2012) 
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It is important that the light is directed into the fovea of the effected eye in order 
to correct diplopia. Important considerations for prism glasses are lens thickness 
and weight. These problems are partially alleviated by the concept known as the 
Fresnel principle.  Rather than having a single thick prism, Fresnel prisms have 
multiple smaller apices lined up to achieve a similar effect. Fresnel prisms can be 
implemented as thin plastic films that can be adhered to standard lenses. The 
downside to Fresnel prisms is the slight loss in clarity that is caused by the series 
of parallel lines made by the apices. (Phillips, 2007)  
 Finally, an important consideration for the correction of strabismus for 
patients with oculomotor palsy is the extent of the ptosis. For patients with 
complete third nerve palsy even after surgery or radiotherapy, diplopia is only 
noticed when the eyelid is lifted up. This fact may render strabismus correction, 
for some patients with oculomotor schwannoma, a moot point. 
Significance 
The diplopia due to third nerve schwannomas can make simple tasks such 
as driving particularly difficult. Unfortunately, very few physicians have seen or 
have experience treating nonvestibular schwannomas. Oculomotor nerve 
schwannomas are a rare occurrence that results in common symptoms. Given 
the rarity of nonvestibular, intracranial schwannomas, many physicians may not 
consider these lesions in their attempts to correct diplopia.  
Interestingly enough, between fifty to sixty cases have been reported 
since Dr. Kovacs’s discovery of an oculomotor schwannoma during an autopsy in 
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1927. The purpose of this case series and review of existing literature was to 
help develop a simple algorithm that physicians can confidently follow in the 
future when treating suspected oculomotor schwannomas. This study aims to 
help improve the treatment of oculomotor schwannomas by ensuring physicians 
know which treatment would best to preserve oculomotor function, while ensuring 
the lesion is effectively managed.  
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METHODS 
 
 A search for oculomotor schwannoma cases on Pubmed, Embase, and 
Google Scholar was conducted according to PRISMA standards. The search 
used the terms “schwannoma,” “neurinoma,” “neurilemoma,” “oculomotor nerve,” 
“third cranial nerve,” “stereotactic radiosurgery,” and “strabismus” in different 
combinations. The search was limited to case reports published from 1980 to 
2015. The search was also limited to English literature with adequate data for 
imaging and follow up. Given these criteria, 51 reported cases were selected for 
this systematic review. Data pertaining to symptoms, symptom duration, age, 
gender, tumor location, tumor size, treatment, treatment outcome, and follow up 
time were extracted. Four additional non published oculomotor schwannoma 
cases from Beth Israel Deaconess Medical Center and Tufts Medical Center 
were included to supplement the data from previous literature. The cases were 
then divided into surgical and non-surgical subgroups for comparison. Surgical 
cases were defined as any case that involved craniotomy and resection of the 
lesion. Cases that were treated with stereotactic radiotherapy only were 
classified as non-surgical. GraphPad software was used to calculate p-values for 
both Fisher’s exact tests and t tests. Statistically significant results were defined 
by a p-value less than 0.05. Based on the statistical analysis from both the 
previous literature and the present case series, a suggested algorithm was 
developed in order to help physicians determine which treatment option is most 
likely to preserve the most remaining oculomotor function.  
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RESULTS 
 
 The literature review yielded a cohort of 51 cases. Table 1 summarizes 
each of the cases that were found. The mean age at diagnosis for the entire 
cohort was 30 years with a range of 2 months to 66 years. The male to female 
ratio was 0.96:1. The mean symptom duration for the cohort was 27.8 months 
with a range of 3 days to 216 months. Mean follow-up time was 25.2 months with 
a range of 1 month to 108 months. Table 2 summarizes demographic 
characteristics, tumor location, and symptoms. 
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Source 
 
Age Gender Symptoms 
Symptom 
Duration 
(Months) Location Size Therapy Outcome 
Follow 
Up 
(months) 
Kauser et 
al., 2014 32 Male Proptosis 6 Orbital/Cavernous 
43x21x19 
mm 
Surgical 
Resection 
Complete 3rd 
Nerve Palsy 4 
Kumar et 
al., 2014 29 Male diplopia 2 Cavernous 
30x25x30 
mm 
Surgical 
Resection 
Complete 3rd 
nerve palsy, 
SRS Treatment 24 
Wang et 
al., 2013 30 Male 
Headache, 
Nausea, 
Diplopia 60 Cisternal NA 
Surgical 
Resection  3rd Nerve Palsy NA 
Asaoka et 
al., 1999 64 Female Headache NA Cisternal 15 mm 
Surgical 
Resection 
Partial 3rd 
Nerve Palsy 6 
Saetia et 
al., 2011 41 Male Vision Loss 6 Cisternal 42.5 cm3 
Surgical 
Rescection 
Partial 3rd 
Nerve Palsy, 
SRS Treatment NA 
Kim et al., 
2008 29 Male Ptosis NA NA 7.4 cm3 
Gamma 
Knife SRS 
Reduced 
Tumor Size 9 
Kim et al., 
2008 19 Female 3rd Nerve Palsy NA Cisternal 0.07 cm3 
Gamma 
Knife SRS 
Reduced 
Tumor Size 36 
Hiscott et 
al., 1982 58 Female Ptosis 6 Cavernous 40 mm 
Surgical 
Resection 
Complete 3rd 
Nerve Palsy NA 
Takano et 
al., 1990 65 Female Ptosis, Diplopia 24 Cavernous 
25x25 
mm 
Surgical 
Resection No change 36 
Leunda et 
al., 1982 11 Male 
Headaches, 3rd 
Nerve Palsy NA Cisternal 55 mm 
Surgical 
Resection 
Complete 3rd 
Nerve Palsy 108 
Kurokawa 
et al., 
1992 55 Male Diplopia 1.3 Cavernous NA 
Surgical 
Resection 
Complete 3rd 
Nerve Palsy 5 
Kadota et 
al., 1993 41 Male Diplopia, Ptosis NA Cisternal 20 mm 
Surgical 
Resection NA NA 
Table 1: Reported cases of oculomotor schwannoma 
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Schultheis
s et al., 
1993 65 Male Asymptomatic NA Cisternal 8 mm 
Surgical 
Resection NA NA 
Shen et 
al., 1993 43 Male Proptosis, Ptosis 84 Cavernous 55 mm 
Surgical 
Resection NA NA 
Kaye-
Wilson et 
al., 1993 23 Female NA NA Cisternal 3 mm 
Surgical 
Resection NA NA 
Niazi et 
al., 1994 13 Male 
Diplopia, 
Headache, 
Ptosis 0.67 Cisternocavernous 50 mm 
Surgical 
Resection 
3rd Nerve 
Palsy, Diplopia 
Improved NA 
Bejjani et 
al., 1997 6 Female Diplopia NA Cisternal 12 mm 
Surgical 
Resection NA NA 
Kachhara 
et al., 
1998 55 Female 
Headache, 
Diplopia, Ptosis 36 Cavernous 20 mm 
Surgical 
Resection 
3rd and 4th 
Nerve Palsy 16 
Kachhara 
et al., 
1998 61 Male 
Headache, 
Diplopia 6 Cisternocavernous 40 mm 
Surgical 
Resection 
3rd and 4th 
Nerve Palsy 12 
Kawasaki 
et al., 
1999 23 Female 
Diplopia, 
Nausea, 
Headache 216 Cisternal 4 mm 
Oral 
prednisone 
Episodic 3rd 
Nerve Palsy 36 
Mariniello 
et al., 
1999 8 Female 3rd Nerve Palsy 96 Cavernous 10 mm 
Surgical 
Resection 3rd Nerve Palsy 24 
Lingawi et 
al., 2000 53 Male Headache 3 Cisternal 5 mm  
Surgical 
Resection 
Oculomotor 
Function Intact 6 
Norman et 
al., 2001 0.17 Male 3rd Nerve Palsy NA Cavernous 3 mm Observation 
3rd Nerve 
Palsy, 
Strabismus 
Surgery 96 
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Norman et 
al., 2001 2 Female Ptosis NA Cisternal NA Observation 
3th Nerve 
Palsy, 
Strabismus 
Surgery 48 
Norman et 
al., 2001 0.17 Male Anisocoria NA Cisternal 7 mm Observation 
3th Nerve 
Palsy, 
Strabismus 
Surgery 11 
Norman et 
al., 2001 3 Female Exotropia NA Cavernous NA Observation 
3th Nerve 
Palsy, 
Strabismus 
Surgery 84 
Norman et 
al., 2001 0.67 Female Anisocoria NA Cavernous NA Observation 
Partial 3rd 
Nerve Palsy 8 
Hatakeya
ma et al., 
2003 33 Male Diplopia, Ptosis 8 Cisternocavernous 40 mm 
Surgical 
Resection 
Oculomotor 
Function Intact 7 
Sarma et 
al., 2002 36 Female 
Diplopia, 3rd 
Nerve Palsy NA Cavernous 7 mm 
Surgical 
Resection 
3rd Nerve 
Palsy, 
Strabismus 
Surgery 96 
Netuka et 
al., 2003 12 Female Headaches 10 Cisternal 
28 x 13 
mm 
Surgical 
Resection 3rd Nerve Palsy 12 
Murakami 
et al., 
2005 11 Female 
Ptosis, Diplopia, 
Headache 60 Cisternal 5 mm 
Surgical 
Resection 
3rd Nerve 
Palsy, 
Strabismus 
Surgery 1 
Bisdorff et 
al., 2006 14 Female 
Headache, 
Ptosis, Diplopia 144 Cisternal 7 mm  Observation No Change 4 
Ohata et 
al., 2006 63 Female 
Headache, 
Ptosis, Diplopia 1 Cavernous 25 mm  
Surgical 
Resection 
Complete 3rd 
Nerve Palsy 72 
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Tanriover 
et al., 
2007 34 Female 
Headache, 
Ptosis, 3rd 
Nerve Palsy 6 Cisternal 17 mm  
Surgical 
Resection 
Improved 
Oculomotor 
Function 5 
Chewning 
et al., 
2008 14 Female 
Ptosis, 
Headaches, 3rd 
Nerve Palsy 0.33 Cisternal 4 mm  Observation No Change NA 
Goel et al., 
2010 32 Male 
Headache, 
Ptosis, Diplopia 3 Cisternal 41 mm 
Surgical 
Resection 
Oculomotor 
Function Intact 52 
Goel et al., 
2010 16 Male 
Headache, 
Ptosis 12 Cavernous 53 mm 
Surgical 
Resection 
3rd and 4th 
Nerve Palsy 12 
Nonaka et 
al., 2014 20 Female 
Headache, 
Dizziness NA Cisternal 
65 x 42 x 
35 mm 
Surgical 
Resection 3rd Nerve Palsy 12 
Nonaka et 
al., 2014 18 Male Ptosis NA Cisternal 5 x 5 mm Observation No Change 24 
Kim et al., 
2014 31 Female 
Diplopia, 
Headache, 
Ptosis 60 Cisternal 3 mm 
IV and oral 
prednisone 
Partial 3rd 
Nerve Palsy 12 
Kim et al., 
2014 52 Male 
Diplopia, 
Headache, 
Ptosis 0.10 Cisternal 3 mm 
IV and oral 
prednisone 
Partial 3rd 
Nerve Palsy 12 
Yang et 
al., 2013 3 Male 
Convulsion, 
Ptosis 0.33 Cisternal 
11 x 12 x 
13 mm 
Surgical 
Resection 
Partial 3rd 
Nerve Palsy 12 
Iijima et 
al., 2014 37 Female 
Cognitive 
Impairment, 
Hydrocephalus 3 Cisternocavernous 
50 x 37 x 
40 mm 
Surgical 
Resection 
Oculomotor 
Function Intact 2 
Prabhu et 
al., 2010 38 Female 
Headache, 
Dizziness, 
Diplopia, Ptosis NA Cisternal 35 mm 
Surgical 
Resection 
Complete 3rd 
Nerve Palsy 6 
Hironaka 
et al., 
2010 5 Male Ptosis 3 Orbital 35 mm 
Surgical 
Resection 3rd Nerve Palsy NA 
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Nagashim
a et al., 
2012 58 Male 
Ocular Pain, 
Blindness 24 Orbitocavernous NA 
Surgical 
Resection 
Complete 3rd 
Nerve Palsy 6 
Senapati 
et al., 
2014 24 Female Diplopia, Ptosis 24 Cisternal 
61 x 36 x 
62 mm 
Surgical 
Resection 
Complete 3rd 
Nerve Palsy 12 
Scheller et 
al., 2013 42 Female 
Anisocoria, 
Exophthalmos 1.67 Orbital 
17.6 x 
13.6 x 
10.5 mm 
Surgical 
Resection No Change 48 
Furtado et 
al., 2012 21 Male Diplopia 6 Cisternocavernous 
15 x 15 
mm 
Surgical 
Resection 
Complete 3rd 
Nerve Palsy 12 
Furtado et 
al., 2012 25 Male 
3rd Nerve Palsy, 
Diplopia 4 Orbitocavernous 
50 x 25 x 
15 mm 
Surgical 
Resection 
Complete 3rd 
Nerve Palsy 15 
Kotah et 
al., 2000 66 Female Asymptomatic NA Cisternocavernous 15 mm 
Surgical 
Resection 
Complete 3rd 
Nerve Palsy 6 
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Table 2: Patient characteristics     N=51 
Age (years)       
Mean 30.1     
Median 29     
Range 0.16 - 66     
Sex      N=51 
Female 26 51%   
Male 25 49%   
Tumor Location      N=50 
Cisternal 26 52%   
Cavernous 13 26%   
Cisternocavernous 6 12%   
Orbitocavernous 3 6%   
Orbital 2 4%   
Tumor Diameter      N=42 
Mean 24.8     
Median 18.8     
Range 3-65     
Symptom Duration (months)      N=35 
Mean 27.8     
Median 6     
Range 0.10 - 216     
Follow Up (months)      N=40 
Mean 25.2     
Median 12     
Range 1-108     
Symptoms      N=51 
Diplopia 23  45.1%   
Headache/Migraines 20  39.2%   
Ptosis 25  49.0%   
Asymptomatic 2  3.9%   
Other 15  29.4%   
 
 Out of the 51 cases, 38 patients underwent surgical resection of the 
schwannoma, while 13 patients either had SRS or clinical observation. Table 3 
presents the differences in patient characteristics between the surgical and non-
surgical subgroups. The mean age of the surgical subgroup (35 years) was 
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significantly higher than the non-surgical subgroup (15.8 years, p=0.0025). The 
surgical subgroup’s mean tumor diameter (29.5 mm) was significantly larger than 
the non-surgical subgroup’s mean tumor diameter (4.5 mm, p=0.0006). The 
surgical subgroup’s mean symptom duration (17.8 months) was significantly 
shorter than the non-surgical symptom duration (140 months, p=0.0001). Non-
surgical patients had longer follow-up times (33.5 months) then surgical patients 
(22.9 months), but this difference was not found to be statistically significant 
(p=0.2923). Differences in the major symptoms reported between the subgroups 
was not statistically significant (p=0.3172). Two cases were asymptomatic. Both 
asymptomatic cases were treated surgically. The two cases treated with Gamma 
Knife SRS, were included in the non-surgical subgroup with a range of dosage 
between 11 and 13 Gy. Both SRS-treated cases reported reduction in tumor size 
and experienced little to no change in post-operative oculomotor function. 
 
Table 3: Surgical vs. non-
surgical patient 
characteristics           
  Surgical N=38 Non-Surgical N=13 P-value 
Age (year)           
Mean 35.0   15.8   0.0025 
Median 33.5   14     
Range 3-66   0.16-52     
Sex    N=38    N=13   
Female 18 47.40% 5 38.50%   
Male 20 52.60% 8 61.50%   
Tumor Location    N=38    N=12   
Cisternal 17 44.70% 9 75.00%   
Cavernous 10 26.30% 3 25.00%   
Cisternocavernous 6 15.80% 0 0%   
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Orbitocavernous 3 7.90% 0 0%   
Orbital 2 5.30% 0 0%   
Tumor Diameter (mm)    N=34    N=8   
Mean 29.5   4.5   0.0006 
Median 26.5   4     
Range 3-65   3-7     
Symptom Duration 
(months)    N=28    N=7   
Mean 17.8   140   0.0001 
Median 6   144     
Range 0.33 - 96   0.10 - 216     
Follow Up (months)    N=28    N=12   
Mean 22.9   33.5   0.2923 
Median 12   18     
Range 1-108   4-96     
Symptoms    N=38    N=13   
Diplopia 19   4   0.3172 
Headaches/migrane 15   5     
Ptosis 18   7     
Other/asymptomatic 16   1     
 
 Table 4 summarizes the post-treatment oculomotor function of the two 
subgroups. The majority of surgical cases (20/38, 52.6%) reported worsened 
oculomotor fuction. The surgical cases that reported no change in oculomotor 
function (6/38, 15.8%) and improved oculomotor function (6/38, 15.8%) 
comprised the minority of surgical cases. These results were significantly 
different from the non-surgical group (p=0.0002). The majority of non-surgical 
cases reported no change in oculomotor function (11/13, 84.6%).   
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Table 4: Surgical vs. 
non-surgical 
postoperative results             
Oculomotor 
Function   Surgical   Non-Surgical     
Worsened   20   2     
No Change   6   11   P-Value 
Improved   6   0   0.0002 
 
Case 1: 
A 50-year-old woman presented with a history of head trauma at age 5. 
After hitting her head, she noticed right ptosis and drifting of the right eye 
outward. The patient also had two surgical strabismus repairs after the head 
trauma that failed to properly align the right eye. On examination, visual acuity 
was 20/400 in the right eye and 20/20 in the left eye. The right pupil was fixed 
and dilated without relative afferent pupillary defect. A Krimsky test showed 50 
PD (prism diopters) of RXT (right exotropia) and 20 PD of RHT (right 
hypertropia). Mild adduction and elevation deficits and a significant depression 
deficit were also noted in the right eye. Given the history of trauma, an initial 
diagnosis of traumatic right third nerve palsy was made, but the progressive 
deviation of the right eye warranted investigation with MRI. Imaging showed an 
8.0 mm enhancing lesion on the right oculomotor nerve consistent with 
schwannoma. Eight months later, 1 fraction of 12 Gy photon SRS treatment was 
administered. No change in the size of the lesion was noted and no change in 
motility was reported 1 year after treatment. 8 months after SRS, a third 
strabismus repair aligned the right eye to a residual 6 PD of RXT and 6 PD of 
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RHT immediately after surgery. One year after the third strabismus repair the 
right eye drifted slightly to 35 PD of RXT and 10 PD of RHT with only mild 
adduction deficit reported. 
Case 2: 
A 46-year-old woman presented with episodes of severe migraine 
headaches since childhood. The episodes were typically followed by a 2 to 3 day 
period of left ptosis and diplopia. After an episode that occurred 3 years before 
presentation, the diplopia persisted. On examination, a right head turn and right 
head tilt was observed. Visual acuity was 20/20 in the right eye and 20/25 in the 
left eye. The left pupil was larger than the right and less reactive to light. Mild left 
upper lid ptosis was also noted. The patient was able to identify four out of nine 
circles on the Titmus stereopsis test. The left eye also presented with limited 
elevation, depression, and adduction. Due to a history of migraine and worsening 
diplopia, an MRI was done. Imaging with gadolinium contrast showed a 5 mm x 5 
mm x 6 mm cisternal enhancing mass along the third cranial nerve consistent 
with schwannoma. The patient underwent one fraction of Gamma Knife SRS with 
a dose of 12 Gy and was provided with prism glasses. Three months after 
Gamma Knife SRS, oculomotor nerve function was stable, and diplopia was 
completely resolved with prism glasses. Six years after treatment, the lesion 
continued to remain stable.  
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Case 3: 
A 63-year-old woman noticed a larger right pupil for 2 months. The patient 
had a history of bilateral cataract extraction with IOL (intraocular lens) 
implantation and macular hole repair in the left eye two years previously. On 
examination, visual acuity in both eyes was 20/20. The right pupil was 2 mm 
larger than the left and had sluggish reaction to light. The patient had full 
extraocular motility. An initial diagnosis of Adie’s tonic pupil was made. Three 
months after examination, the patient noted intermittent double vision when lying 
down. Due to worsening diplopia, MR imaging was ordered. Imaging showed a 3 
mm x 8 mm x 12 mm, T2 hyperintense, and enhancing lesion extending from the 
cavernous sinus to the orbital apex consistent with schwannoma. Given the 
proximity of the lesion to the optic nerve, the decision was made to continue 
observation. Four months after imaging, the patient reported worsening double 
vision when looking downward. Two months after that, repeat imaging 
demonstrated no change in the size of the lesion. Another two months after 
repeat imaging, significant worsening of third nerve palsy was noted with 
significant adduction, depression, and elevation deficits in the right eye. The 
patient measured 18 PD of RXT and 2 PD of RHT that would increase to 30 PD 
of RXT and 2 PD of RHT when looking to the left. As a result of worsening 
diplopia, a 46.8 Gy dose of proton SRS was administered over 26 fractions. Six 
months after SRS treatment, no change in the size of the lesion was noted and 
medial rectus atrophy was reported. 8 months after SRS treatment, third nerve 
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palsy worsened, and the right eye motility was noticeably worse with complete 
adduction, elevation, and depression deficits. 27 months after SRS the right eye 
was completely fixed in the abducted position. Five years after SRS treatment, 
imaging showed no change in tumor size. 
 
Case 4: 
 A 42-year-old woman with a lifelong history of diplopia noticed a 
worsening of diplopia and increased drifting of the right eye over a two-month 
period after an upper respiratory infection. The patient had previous strabismus 
repair surgeries but slowly worsening third nerve palsy over the years, preventing 
proper alignment. On examination, visual acuity in both eyes was 20/15. The 
right pupil was larger than the left. The patient had 60 PD of RXT and 20 PD of  
LHT (left hypertropia) in the primary position. Due to worsening diplopia, MR 
imaging was ordered. Imaging showed an enhancing lesion extending from the 
cavernous sinus through the orbital fissure and into the orbit. A total dose of 48.6 
Gy over 27 fractions of SRS was administered. Six weeks after SRS treatment, 
an improvement in right ptosis was reported, and the patient measured 45 PD of 
RXT and 15 PD of LHT in the primary position. Nine years after treatment, the 
patient underwent another strabismus repair in the right eye. Six months after 
strabismus repair, the patient reported no diplopia in the primary position. 
Approximately 10 years after SRS treatment, repeat imaging showed no change 
in tumor size. 
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 Figure 10 presents our suggested flowchart for a standardized method to 
preserve oculomotor function when treating oculomotor schwannomas. The 
results of the literature review and our case series prompted us to categorize 
schwannomas first as symptomatic and asymptomatic. The two asymptomatic 
schwannomas described in the literature review were surgically removed and 
resulted in complete third nerve palsy (Katoh et al., 2000) (Schultheiss et al., 
1993). The two cases treated solely with SRS experienced temporary periods of 
oculomotor palsy due to radiation injury. This period of third nerve palsy later 
cleared up during follow-up (Kim et al., 2008). Given these results, we suggest 
observing asymptomatic schwannomas until symptoms arise in order to minimize 
the risk of any iatrogenic injury of a completely functional oculomotor nerve. 
Symptomatic schwannomas were further categorized based on the significant 
results of the literature review. The majority of the non-surgical subgroup 
experienced no change in oculomotor function and had significantly smaller 
tumors than the surgical subgroup. In order to preserve any remaining 
oculomotor function, we suggest that smaller tumors, which pose less risk of 
compressive brain injury, be treated with less invasive means, like SRS and 
strabismus repair. If SRS fails to keep tumor size stable and oculomotor function 
continues to worsen, then surgical resection might be indicated. The majority of 
surgically treated cases experienced complete third nerve palsy after surgery. 
Given the potential of complete third nerve palsy, we suggest that surgical 
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resection be used for large tumors that could result in serious compressive brain 
injury. The literature review also described a case were SRS proved to be an 
effective means of controlling tumor size in the event of an incomplete tumor 
resection (Kumar et al., 2014) (Saetia et al., 2011). 
 
  
Figure 10: Suggested flowchart for oculomotor nerve schwannoma 
management 
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DISCUSSION 
 
 Given the rarity of oculomotor nerve schwannomas, there is little 
consensus on how these tumors should be treated. In our literature review, we 
found 51 cases reported between 1980 and 2015. Given the long period of time 
and geographical diversity among the cases, techniques and treatments varied 
widely in the cohort. This variability is manifested in the large ranges for follow-up 
time and symptom duration. A wide variety of surgical approaches were also 
used within the surgical subgroup. However, most cases utilized MR imaging to 
accurately determine the size and location of the lesions. MR imaging in these 
cases demonstrated that oculomotor schwannomas are typically found in the 
subarachnoid cisterns, in between the pia mater and the arachnoid, or in the 
cavernous sinus, a dural venous sinus involved in the venous circulation of the 
brain. Schwannomas were also seen bridging the two compartments and were 
described as cisternocavernous. Schwannomas could also be found extending 
into the orbit, as described in Case 4 and five cases reported in the literature 
(Scheller et al., 2013) (Furtado et al., 2012) (Kauser et al., 2014) (Hironaka et al., 
2010) (Nagashima et al., 2012).  
 While schwannomas have a distinct hyperintense appearance in 
gadolinium contrasted MRI scans, only histological analysis can definitively 
identify schwannomas. The primary histological indicators for schwannomas 
include the presence of highly cellular, palisading, Antoni A zones and less 
cellular, mucin-filled Antoni B zones (Wippold et al., 2006) (McLendon et al., 
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2000). A key biochemical indicator of schwannomas is the over expression of 
protein S-100 (Weiss et al., 1983). The pathological analysis necessary to 
definitively diagnose schwannomas could only be performed in the surgical 
subgroup cases. The oculomotor nerve can experience similar compressive 
damage from meningiomas and aneurysms of the internal carotid artery which 
passes through the cavernous sinus near the oculomotor nerve (Lee et al., 
2016).         
 Besides two asymptomatic cases, all of the cases in the literature review 
and the additional case series experienced at least one or both of the common 
symptoms of third nerve palsy: diplopia (23 cases) and ptosis (25 cases). 
Another presentation was similar to ophthalmoplegic migraines (20 cases), which 
involve brief periods of ptosis and diplopia during or following a migraine, which 
was seen in Case 2. Space occupying lesions may mimic ophthalmoplegic 
migraines due to compression of the oculomotor nerve or the trochlear nerve 
(Murakami et al., 2005). Other unique symptoms reported included hydrocephaly, 
loss of cognitive function, and nausea. Most of these unique symptoms were the 
result of displaced or compressed brain tissue due to particularly large lesions 
and warranted surgical intervention (Iijima et al., 2014) (Wang et al., 2013). 
Another potential feature of oculomotor nerve schwannomas is the atrophy of the 
extraocular muscles that are innervated by the oculomotor nerve, which was 
seen in Case 3 (Szigiato et al., 2016).  
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 Despite the wide variations between follow-up time, symptom duration, 
and treatments, the literature review draws attention to a few statistically 
significant trends. Patients with larger tumors where more likely to undergo 
surgical intervention. This trend is likely due to the risk posed by very large 
schwannomas of displacing more soft tissue, leading to symptoms discussed 
previously or more serious complications. The mean symptom duration for 
surgical patients was also significantly shorter than that of non-surgical patients. 
It is possible that this trend could imply that an acute onset of symptoms 
prompted physicians to favor surgery or is possibly correlated with larger tumors. 
The differences in symptom duration as well as follow-up time between the 
subgroups is further confounded due to the heterogeneity of the literature review 
which compares patients from all over the world without a control group.  
 Surgical intervention was also more likely to result in complete third nerve 
palsy, likely due to the difficulty of maintaining the integrity of the oculomotor 
nerve during resection. The risk of oculomotor nerve damage during surgery has 
prompted some physicians to adopt a more passive approach for patients without 
any life threatening symptoms, partial third nerve palsy, or stable tumors (Katoh 
et al., 2000). Two cases in the literature review mentioned the use of SRS. Both 
of these cases reported a reduction in tumor size (Kim et al., 2008). All of the 
patients in our case series underwent SRS and all of the cases experienced no 
tumor growth. These results corroborate with previous studies reporting the 
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efficacy of SRS in managing cranial nerve schwannomas (Kim et al., 2008) 
(Pollock et al., 2002). 
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